Albert Labs announces Strategic Investment from Cantheon Capital LLC for First In-Human TrialsMindMed Reports Full Year 2022 Financial Results and Business HighlightsCybin to Participate in the Oppenheimer 33rd Annual Healthcare ConferenceNuminus to Participate in the Sequire Cannabis & Psychedelics Conference on Wednesday, April 5, 2023Braxia Scientific Provides Update on Proposed Irwin Transaction; Company Retains Strategic Clinical Assets and Ketamine Numinus Announces Four Peer-Reviewed Publications from its Chief Clinical Officer in 2023Irwin Naturals Signs Letter of Intent to Acquire Braxia ScientificNuminus Wellness Inc. Reports Q1 2023 ResultsIrwin Naturals and Braxia Scientific Announce Partnership for In-Human Clinical Studies Supporting Pharmaceutical CompanNuminus Develops Mushroom Tea for Use in Psychedelic ResearchIs the Psychedelic Sector Poised for a Comeback?!?PSYC + Nucleus Form New Partnership to Develop and Launch Psychedelic FinderWhat You Need to Know About Numinus Wellness…Numinus provides update on acquisition integration and announces new client financing optionsPSYC Corp’s Psychedelic Spotlight Surpasses One Million Page Views for Fourth Consecutive MonthNuminus to Participate in the H.C. Wainwright 24th Annual Global Investment Conference on September 12-14, 2022The Psychedelic Sector is Quietly Outperforming the S&P 500PSYC Completes and Publishes 2021 Audited Financials; Will Begin Audit of Q1 & Q2 2022Numinus to Participate in the H.C. Wainwright 24th Annual Global Investment Conference on September 12-14, 2022PSYC’s Bonfire Platform Development Progresses; Will Host Free Virtual Community Event on August 29th

A Can’t Miss Opportunity: CNRP Mining Selected for Exclusive “Connecting the Dots” Report

Oct 30, 2017 • 11:36 AM EDT
Canada Stocks (97)_1.png
3 MIN READ  •  By Michael Berger
Share Share - Facebook Share - Twitter

Yesterday, released its highly anticipated “Connecting the Dots” report, covering CNRP Mining Inc. (CRPGF) and we wanted to provide some more insight after this informative report was published.

In late July, we initiated coverage on CNRP Mining after the company announced a deal to acquire X-Sprays, a brand of state-of-the-art life-enhancement products administered via an optimal oral spray delivery system.

From sleep to energy, X-Sprays proprietary product line is focused on areas that have a huge addressable market. The company is also levered to a trend toward smokeless marijuana products and we expect this product to resonate with people who do not even want to consume marijuana oil.

Shares Bounce Higher After the Signing of a Definitive Agreement

Last week, CNRP Mining traded higher after the company signed a definitive agreement to acquire X-SPRAYS. This acquisition is significant as it will provide the company with an exclusive world-wide license to an existing line of CBD infused nutraceutical products that are already being sold.

CNRP has been executing on all cylinders and earlier this month, the company closed on a $3 million non-brokered private placement offering.  X-Sprays proprietary product line is comprised of eight health care and life enhancement nutraceutical products that include both hemp CBD and nutraceutical ingredients (4 with CBD and 4 nutraceutical).

One of the attractive aspects of X-Sprays; fundamental story pertains to the minimal capital and resources needed to enter new markets. X-Sprays is implementing a multi-faceted distribution strategy and will use traditional retail outlets, its e-commerce outlet, and non-traditional retail outlets

A Unique Natural Product Targeting Major Indications

CRPGF is targeting indications with a massive addressable market and has focused its efforts on creating a natural product line of oral sprays to deliver medicines, nutrients and vitamins. The product contains natural fruit or mint flavors and are free of: artificial flavors, artificial colors, sugar, starch, wheat, soy, gluten, eggs, salt and dairy.

X-Sprays’ product provides a precise dose and each one contains a 30-day supply when used as suggested (8 sprays every day). The company’s products include:

  • Pain relief – Fast acting and non-addictive
  • Awareness – Increases focus naturally
  • Sleep – Improves sleep without addictive additives
  • Libido – Enhances your libido naturally 
  • Energy – Caffeine free and quick acting formula
  • Recovery – A dose of natural ingredients to help you get through any day

A Multi-Billion-Dollar Market Opportunity

Earlier this year, Research and Markets released a new report published by BCC Research which said that the global nutraceutical market should be a $285 billion market by 2021.

According to BCC Research, nutraceutical products can enjoy significant price premiums over the nearest ordinary competitive products (can cost 1,500% more). We do not expect this trend to end anytime soon as consumers are willing to pay higher prices for products that support health.  

BCC Research Editorial Director Kevin Fitzgerald said, “Despite a trend of reduced consumer spending in the wake of the economic downturn, consumers are willing to pay a significant premium for fortified or high-nutrition products. They’re investing in their health.”

Market Responds Favorably, A Stock You Cannot Miss

X-Sprays is led by a management team has more than 20 years of relevant experience and has demonstrated an ability to create value for its shareholders. The company is levered to a multi-billion-dollar market and offers a product that is effective and differentiated from the competition.

We are favorable on the recent developments and believe that signing of a definitive agreement as well as the closing of the financing have CNRP well positioned to execute on its operating plan.

We will continue to monitor how this team continues to execute and deliver value to its shareholders. CRPGF is a company that we will continue to monitor and believe this is stock that needs to be watched!

Reach out to for more information 


Share Share - Facebook Share - Twitter


Authored By

Michael Berger

Michael Berger is Managing Partner of StoneBridge Partners, LLC and Founder of Prior to entering the cannabis industry, Michael was an Equity Research Analyst at Raymond James Financial covering the Energy Sector. Michael has been featured in publications such as The Street, Bloomberg, US Money News, and hosts various cannabis events across North America.


Top Stories

Get the Latest Cannabis News & Stock Picks.

Enter your email below to join the official Mushroomstocks newsletter.

 All good -- no spamming here.

The psychedelics sector is starting to take off as smart money begins to position itself across the industry.

Stay updated with all latest updates,upcoming events & much more.